Journey Medical Names Alloush COO

Dow Jones
04-02
 

By Stephen Nakrosis

 

Journey Medical has named Ramsey Alloush, currently its general counsel, to be its chief operating officer.

Alloush, who will continue to serve as general counsel, joined Journey Medical in 2020, the pharmaceutical company said Tuesday.

As general counsel Alloush helped guide the company through its initial public offering in 2021. Prior to that, he advised biopharmaceutical companies on corporate transactions and securities matters. He also served as a legal fellow at the Securities and Exchange Commission focusing on enforcement matters.

Journey Medical primarily focuses on marketing and selling Food and Drug Administration-approved prescription pharmaceutical products to treat dermatological conditions.

 

Write to Stephen Nakrosis at stephen.nakrosis@wsj.com

 

(END) Dow Jones Newswires

April 01, 2025 16:27 ET (20:27 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10